Martin Shkreli, former CEO of Turing Pharmaceuticals, is escorted by FBI officials from his arraignment last Thursday in U.S. Federal Court in New York, where he faced security fraud charges.
(Reuters) - Turing Pharmaceuticals said on Tuesday it is seeking a new chief executive to replace Martin Shkreli, the price-gouging entrepreneur who is facing U.S. charges of securities fraud, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback